STUDY OBJECTIVES: Establishing standardized and controlled system of work at a clinical pharmacy department and establishing effective recording of activities of a group of four clinical pharmacist when providing clinical pharmaceutical care (CPC) in a hospital. METHODS: The duration of evaluated period is 5.5 years. The first part was defining the purpose, methods and activities of clinical pharmaceutical care, the next part was designing the software for recording patient's data and CPC activities. To verify the functionality of our system the third part was conducted (from January 1, 2015 to June 30, 2015). RESULTS: CPC activities were defined precisely. During the 6 months period, 3946 patients were reviewed (17% of patients admitted), in this group, 41% patients was labeled as risk (these patients had one or more risk factor). 1722 repeated reviews were performed, 884 drug therapy recommendations were recorded. The calculated average time necessary for one CPC activity is 28 min. CONCLUSION: During the 5 year period, standardized system of work in clinical pharmacy department was established. This system is based on clearly defined activities and it enables external control. Our results supply data for negotiations with health insurance companies.

Department of Applied Pharmacy University of Veterinary and Pharmaceutical Sciences Palackeho tr 1946 1 Brno 612 42 Czech Republic

Department of Clinical Pharmacy Hospital Na Bulovce Budinova 67 2 Prague 180 81 Czech Republic

Zobrazit více v PubMed

American College of Clinical Pharmacy Standards of Practice for Clinical Pharmacists. Pharmacotherapy. 2014;34(8):794–797. Available from: http://www.accp.com/docs/positions/guidelines/StndrsPracClinPharm_Pharmaco8-14.pdf. PubMed

Gallagher J. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC Health Ser Res. 2014;14:177. PubMed PMC

Kuo G.M. Drug errors and related interventions reported by United States clinical pharmacists: the American Colledge of Clinical Pharmacy practise-based research network medication error detection, amelioration and prevention study. Pharmacotherapy. 2013;33(3):253–265. PubMed

LaPointe N.M., Jollis J.G. Medication errors in hospitalized cardiovascular patients. Arch. Intern. Med. 2003;163(12):1461–1466. PubMed

Nesbit T.W. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am. J. Health Syst. Pharm. 2001;58(9):784–790. PubMed

Patel R. The impact of a pharmacist’s participation on hospitalists’ rounds. Hosp Pharm. 2010;45(2):129–134.

Schumock G.T. Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy. 2003;23(1):113–132. PubMed

Talasaz A.H. The potential role of clinical pharmacy services in patients with cardiovascular diseases. J. Tehran Heart Cent. 2012;7(2):41–46. PubMed PMC

Viktil K.K., Blix H.S. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin. Pharmacol. Toxicol. 2008;102(3):2775–2780. PubMed

Zaal R.J. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts. Int. J. Clin. Pharm. 2013;35:753–757. PubMed

ESCP best practice: development of the national methodology for the provision of clinical-pharmaceutical care and its implementation in the healthcare system of the Czech Republic